U.S. flag

An official website of the United States government

GRCh37/hg19 17p13.3(chr17:858365-1690452)x3 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 1, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001832935.1

Allele description [Variation Report for GRCh37/hg19 17p13.3(chr17:858365-1690452)x3]

GRCh37/hg19 17p13.3(chr17:858365-1690452)x3

Genes:
Variant type:
copy number gain
Cytogenetic location:
17p13.3
Genomic location:
Chr17: 858365 - 1690452 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 17p13.3(chr17:858365-1690452)x3
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV002096043Quest Diagnostics Nichols Institute San Juan Capistrano
    no assertion criteria provided
    Pathogenic
    (Mar 1, 2021)
    germlineclinical testing

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002096043.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testingnot provided

    Description

    The copy number gain of 17p13.3 involves multiple genes including YWHAE (OMIM 605066), BHLHA9 (OMIM 615416), CRK (OMIM 164762) and PRPF8 (OMIM 607300) and is expected to cause phenotypic and/or developmental abnormalities. Duplications of this region, involving YWHAE but not PAFAH1B1, have been associated with the class I type of chromosome 17p13.3 duplication syndrome (OMIM 613215) featured with intellectual impairment, autism, occasional structural brain abnormalities and possibly early overgrowth. Incomplete penetrance and highly variable expressivity are characteristic of this duplication syndrome. Inter- and intrafamilial variability is typical, especially in cognitive development, and appears to be at least partially dependent on the size of the duplication and genes involved. Duplications of YWHAE and flanking genes such as CRK are most commonly associated with autism spectrum disorders (Curry et al., Am J Med Genet A. 2013 Aug;161A(8):1833-52. PMID: 23813913; Henry et al. Eur J Med Genet. 2016 Oct;59(10):512-6; PMID: 27633569). A de novo 231 Kb gain including YWHAE and CRK was reported in a patient with developmental delay (Crippa et al., Front Genet. 2019 Oct 15;10:955. PMID: 31749829). The present gain interval also overlaps the region, including BHLHA9, associated with split-hand/foot malformation with long bone deficiency-3 (OMIM 612576), which is less than 50% penetrant and shows markedly variable expressivity. In addition, heterozygous pathogenic sequence variants of PRPF8 (missense and truncating) have been associated with autosomal dominant retinitis pigmentosa 13 (OMIM 600059).

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Mar 26, 2023